Skip to content
10-Q

Quarterly Report

PAR PHARMACEUTICAL COMPANIES, INC.

0000878088-14-000014

← back to feed
Filed
May 15, 2014 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2014 · May 15, 2014 100 sh
Long Term Debt Q1 2014 · Mar 31, 2014 $1.91B
Long Term Debt Q1 2014 · Dec 31, 2013 $1.52B
Short Term Debt Q1 2014 · Mar 31, 2014 $9.47M
Short Term Debt Q1 2014 · Dec 31, 2013 $21.46M
Stockholders Equity Q1 2014 · Mar 31, 2014 $618.36M
Stockholders Equity Q1 2014 · Dec 31, 2013 $547.36M
Current Liabilities Q1 2014 · Mar 31, 2014 $286.12M
Current Liabilities Q1 2014 · Dec 31, 2013 $258.97M
Current Assets Q1 2014 · Mar 31, 2014 $573.74M
Current Assets Q1 2014 · Dec 31, 2013 $465.58M
Total Assets Q1 2014 · Mar 31, 2014 $3.17B
Total Assets Q1 2014 · Dec 31, 2013 $2.63B
Capex Q1 2014 · Mar 31, 2013 $4.41M
Operating Cash Flow Q1 2014 · Mar 31, 2013 $6.11M
Cash And Equivalents Q1 2014 · Mar 31, 2013 $40.16M
Cash And Equivalents Q1 2014 · Dec 31, 2012 $36.79M
Sga Expense Q1 2014 · Mar 31, 2013 $40.8M
Rd Expense Q1 2014 · Mar 31, 2013 $20.22M
Net Income Q1 2014 · Mar 31, 2013 −$14.75M
Operating Income Q1 2014 · Mar 31, 2013 $8.61M
Gross Profit Q1 2014 · Mar 31, 2013 $71.44M
Cost Of Revenue Q1 2014 · Mar 31, 2013 $218.75M
Revenue Q1 2014 · Mar 31, 2013 $290.2M